Ji L, Liu C, Li P, Wang X, Liu C, Hou Y
Sci Rep. 2018; 8(1):115.
PMID: 29311630
PMC: 5758522.
DOI: 10.1038/s41598-017-18520-6.
Betgem R, de Waard G, Nijveldt R, Beek A, Escaned J, van Royen N
Nat Rev Cardiol. 2014; 12(3):156-67.
PMID: 25403783
DOI: 10.1038/nrcardio.2014.188.
Hofmann M, Genth K, Schaper W
Basic Res Cardiol. 1980; 75(4):572-82.
PMID: 7437000
DOI: 10.1007/BF01907838.
Dalen J, Ockene I, Alpert J
Trans Am Clin Climatol Assoc. 1981; 93:87-97.
PMID: 7345722
PMC: 2279528.
Engler R, Schmid-Schonbein G, Pavelec R
Am J Pathol. 1983; 111(1):98-111.
PMID: 6837725
PMC: 1916203.
Mitochondrial damage during myocardial ischemia.
Regitz V, Paulson D, Hodach R, Little S, Schaper W, Shug A
Basic Res Cardiol. 1984; 79(2):207-17.
PMID: 6743190
DOI: 10.1007/BF01908307.
Thrombolytic effects of intracoronary streptokinase on canine coronary artery thrombosis.
Fiedler V
Basic Res Cardiol. 1984; 79(1):17-26.
PMID: 6732717
DOI: 10.1007/BF01935803.
Percutaneous transluminal coronary artery recanalization in evolving myocardial infarction.
Rentrop P, Blanke H
Cardiovasc Intervent Radiol. 1982; 5(3-4):194-6.
PMID: 6217891
DOI: 10.1007/BF02552309.
The "no-reflow" phenomenon after temporary coronary occlusion in the dog.
Kloner R, GANOTE C, Jennings R
J Clin Invest. 1974; 54(6):1496-508.
PMID: 4140198
PMC: 301706.
DOI: 10.1172/JCI107898.
Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.
Flameng W, Van de Werf F, Vanhaecke J, Verstraete M, Collen D
J Clin Invest. 1985; 75(1):84-90.
PMID: 4038406
PMC: 423408.
DOI: 10.1172/JCI111701.
Depletion of membrane phospholipid and mitochondrial dysfunction associated with coronary reperfusion.
Hattori M, Ogawa K, Satake T, Sugiyama S, Ozawa T
Basic Res Cardiol. 1985; 80(3):241-50.
PMID: 4026784
DOI: 10.1007/BF01907900.
Prevention of the "no reflow" phenomenon in the canine heart by mioflazine.
Flameng W, XHONNEUX R, Vanhaecke J, Van de Water A, Suy M
Basic Res Cardiol. 1985; 80(1):27-36.
PMID: 3985924
DOI: 10.1007/BF01906741.
Coronary artery ligation and reperfusion in alloxan-diabetic rabbits: ultrastructural and haemodynamic changes.
Bhimji S, Godin D, McNeill J
Br J Exp Pathol. 1986; 67(6):851-63.
PMID: 3801299
PMC: 2013130.
Differing time courses between delta lactate and mitochondrial respiration during coronary occlusion and after reperfusion in canine hearts.
Hanaki Y, Sugiyama S, Taki K, Kato T, Suzuki S, Ozawa T
Heart Vessels. 1988; 4(3):149-52.
PMID: 3248982
DOI: 10.1007/BF02058427.
Intracoronary thrombolysis: organizational prerequisites, technique, and results.
Rutsch W, SCHMUTZLER H
Cardiovasc Intervent Radiol. 1986; 9(5-6):245-52.
PMID: 2948642
DOI: 10.1007/BF02577953.
Myocardial protection by a left ventricular assist device during reperfusion following acute coronary occlusion.
Nishi K, Mori F, Miyamoto M, Esato K
Jpn J Surg. 1989; 19(5):563-9.
PMID: 2593391
DOI: 10.1007/BF02471664.
Evaluation of the protective effect of verapamil on reperfusion injury by 111In anticardiac myosin antibody in canine myocardial infarction.
Chung J, Lim S, Lee M, Koh C, Lee M, Seo J
Ann Nucl Med. 1991; 5(3):109-15.
PMID: 1764340
DOI: 10.1007/BF03164623.
Cardiovascular effects of acebutolol following coronary artery occlusion and reperfusion in anaesthetized dog.
Chernecki W, Das P, Dhalla N, Sharma G
Br J Pharmacol. 1978; 64(2):265-72.
PMID: 708995
PMC: 1668318.
DOI: 10.1111/j.1476-5381.1978.tb17299.x.
Changes in ventricular fibrillation threshold during repeated short-term coronary occlusion and release.
Gulker H, Kramer B, Stephan K, MEESMANN W
Basic Res Cardiol. 1977; 72(5):547-62.
PMID: 588206
DOI: 10.1007/BF01910416.
Myocardial substrate utilization and hemodynamics following repeated coronary flow reduction in pigs.
Verdouw P, Remme W, de Jong J, Breeman W
Basic Res Cardiol. 1979; 74(5):477-93.
PMID: 526255
DOI: 10.1007/BF01907642.
